<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="4964">
  <stage>Registered</stage>
  <submitdate>1/05/2015</submitdate>
  <approvaldate>1/05/2015</approvaldate>
  <nctid>NCT02441400</nctid>
  <trial_identification>
    <studytitle>EndoStim Patient Registry</studytitle>
    <scientifictitle>EndoStim Patient Registry-LES Stimulation System for the Treatment of GERD</scientifictitle>
    <utrn />
    <trialacronym>RESTORE</trialacronym>
    <secondaryid>CS500</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>GERD</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - EndoStim LES Stimulation System

EndoStim LES Stimulation System implant. - Registry subjects whom have been implanted commercially with the EndoStim LES Stimulation System device.


Treatment: devices: EndoStim LES Stimulation System


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Safety will be assessed by incidence and severity of adverse events through 60-month (5 years) follow-up.</outcome>
      <timepoint>5 years post implant</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in GERD-HRQL (vs. baseline)</outcome>
      <timepoint>5 years post-procedure.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Comparisons of pH values (vs. baseline)</outcome>
      <timepoint>5 years post-procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Comparison of symptoms (measured by patient symptom diary) and patients quality of life measured by SF-12 (vs. baseline)</outcome>
      <timepoint>5 years post-procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in antisecretory medication use (vs. baseline)</outcome>
      <timepoint>5 years post-procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in structured GI Questionnaire responses (vs. baseline)</outcome>
      <timepoint>5 years post-procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in sleep related quality of life as measured by the Pittsburgh Sleep Quality Index (PSQI) (vs. baseline)</outcome>
      <timepoint>5 years post-procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>g. Change in work productivity impairment (on and off PPI periods) as measured by the Work Productivity and Activity Impairment Questionnaire: Specific Health Problem V2.0 (WPAI:SHP) (vs. baseline)</outcome>
      <timepoint>5 years post-procedure</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in RDQ scores (vs. baseline)</outcome>
      <timepoint>5 years post-procedure</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Subject signs informed consent

          -  Subject has a planned EndoStim LES Stimulation System implant (prospective) OR subject
             has already had his/her EndoStim LES Stimulation System implant (retrospective)</inclusivecriteria>
    <inclusiveminage>21</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Subject is contraindicated for implantation of the EndoStim LES Stimulation System
             implant

               -  Significant cardiac arrhythmia, ectopy, or significant cardiovascular disease

               -  Pregnant or nursing

          -  Subject is less than 22 years old or greater than 75 years old</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational [Patient Registry]</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/05/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>350</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/05/2019</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>St. George Hospital - Kogarah</hospital>
    <postcode> - Kogarah</postcode>
    <countryoutsideaustralia>
      <country>Argentina</country>
      <state>Buenos Aires</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>Vienna</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Colombia</country>
      <state>Bogotá</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Denmark</country>
      <state>Aarhus</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Castrop Rauxel</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Friesoythe</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Herne</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Köln</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Memmingen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Siegen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Monterrey</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Maastricht</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state>Bern</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>EndoStim Inc.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>To provide a research tool enabling physicians to monitor long term clinical outcomes for
      patients undergoing gastroesophageal reflux disease (GERD) treatment with EndoStim LES
      Stimulation System.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02441400</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Virender K Sharma, MD</name>
      <address />
      <phone />
      <fax />
      <email>vksharma@endostim.com</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>